Raymond James initiated coverage on shares of Alignment Healthcare (NASDAQ:ALHC) in a report released on Tuesday morning, The Fly reports. The brokerage issued an outperform rating and a $30.00 target price on the stock.

A number of other research analysts also recently issued reports on the stock. UBS Group initiated coverage on shares of Alignment Healthcare in a research report on Tuesday. They issued a neutral rating and a $28.00 price objective on the stock. Piper Sandler began coverage on shares of Alignment Healthcare in a research report on Tuesday. They issued an overweight rating and a $30.00 price objective on the stock. Bank of America began coverage on shares of Alignment Healthcare in a research report on Tuesday. They set a neutral rating and a $29.00 target price on the stock. The Goldman Sachs Group began coverage on shares of Alignment Healthcare in a research report on Tuesday. They set a neutral rating and a $25.00 target price on the stock. Finally, Morgan Stanley assumed coverage on shares of Alignment Healthcare in a research report on Tuesday. They set an overweight rating and a $36.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $29.67.

Shares of Alignment Healthcare stock opened at $23.00 on Tuesday. Alignment Healthcare has a 52-week low of $16.32 and a 52-week high of $26.17.

In related news, CFO Robert Thomas Freeman sold 38,919 shares of the business’s stock in a transaction on Tuesday, April 6th. The shares were sold at an average price of $16.83, for a total value of $655,006.77. Following the completion of the transaction, the chief financial officer now directly owns 223,347 shares in the company, valued at approximately $3,758,930.01. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Michael Curtis Foster sold 50,843 shares of the business’s stock in a transaction on Tuesday, April 6th. The shares were sold at an average price of $16.83, for a total transaction of $855,687.69. Following the completion of the transaction, the insider now owns 1,132,692 shares of the company’s stock, valued at $19,063,206.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 806,386 shares of company stock valued at $13,571,476.

About Alignment Healthcare

Alignment Healthcare, Inc operates as a health insurance company in the United States. Its technology platform, Alignment's Virtual Application is designed specifically for senior care and provides end-to-end coordination of the healthcare ecosystem. The company's product portfolio consists of Medicare Advantage plans and Preferred Provider Organization.

Further Reading: NASDAQ

The Fly

Analyst Recommendations for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.